Liu-Zi-Jue Qigong and Acupressure Therapy for Pulmonary Function and Quality of Life in Patient with Severe novel coronavirus pneumonia (COVID-19): A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2000003036

Enrollment

Unknown

Registered

2020-02-18

Start date

2020-02-19

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Experimental group:Conventional treatment +acupressure+Liuzijue qigong

Control group:Conventional treatment

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meet NCP critical diagnosis criteria; (2) Volunteer to participate in this study, cooperate with examination and treatment; (3) The selected patients were basically stable, conscious and cooperative; (4) No serious mental disorder; (6) Aged between 20-80 years.

Exclusion criteria

Exclusion criteria: 1. Patients with other serious diseases such as lung diseases, cardiovascular and cerebrovascular diseases, hematopoietic diseases, autoimmune diseases, digestive system, or mental illness; 2. Pregnant or lactating women; 3. Participate in other forms of exercise during the trial

Design outcomes

Primary

Measure	Time frame
6min walk;ADL;lung function;	—

Secondary

Measure	Time frame
PHQ-9;Respiratory symptoms;Length of hospital stay;LUNG CT;immune cells;Liver and renal function test;	—

Countries

China

Contacts

Public ContactFang Lei

Faculty of Rehabilitation Medicine, Shanghai University of Chinese Medicine

fanglei586@126.com+86 021-51323092

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026